Verrica Pharmaceuticals (VRCA) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

Net buying: insiders sold $0 and bought $110K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$110K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about VRCA filings

Are insiders buying or selling Verrica Pharmaceuticals Inc (VRCA) stock?

Net buying: insiders sold $0 and bought $110K of VRCA stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Rosenberg, Noah L. (CMO), who bought $31K. The latest filing was on Aug 18, 2026.

Which members of Congress have traded VRCA recently?

None. No member of Congress disclosed a VRCA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this VRCA smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on VRCA

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $186K
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about VRCA filings

Are insiders buying or selling Verrica Pharmaceuticals Inc (VRCA) stock?

Which members of Congress have traded VRCA recently?

None. No member of Congress disclosed a VRCA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this VRCA smart-money data?

Insiders

What insiders are doing

4 trades · 6 mo

Bought$211K

Buys (3)

RJ
Rieger Jayson
CEO and President · Cluster · Aug 18
$126K
bought
Signals like this: n=2459, 52% finished lower at D15, median -0.4% vs SPY +0.2%
RN
Rosenberg Noah L.
CMO · Cluster · Aug 18
$31K
bought
ZD
Zawitz David
Chief Operating Officer · Cluster · Aug 18
$30K
bought

1 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.49+0.51% in line

-$0.49 expected

Revenue

$6.9M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$0.49est. -$0.49	+0.51%in line	$6.9MSEC filing	-51.8%from $14.3M
Jun 30, 2026Reported Aug 6, 2026	-$0.48est. -$0.47	-2.86%miss	$5.9MSEC filing	-53.8%from $12.7M
Mar 31, 2026Reported May 12, 2026	-$0.45est. -$0.59	+22.98%beat	$5.0MSEC filing	+46.1%from $3.4M
Dec 31, 2025Reported Mar 11, 2026	-$0.51est. -$0.64	+20.31%beat	$5.1MYahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 14, 2025	-$0.03est. -$0.06	+$0.03beat	$14.3MSEC filing	No year-ago quarter
Jun 30, 2025Reported Aug 12, 2025	$0.25est. -$0.83	+130.12%beat	$12.7MSEC filing	+145.4%from $5.2M
Mar 31, 2025Reported May 13, 2025	-$1.00est. -$1.36	+26.47%beat	$3.4MSEC filing	-10.1%from $3.8M
Dec 31, 2024Reported Mar 11, 2025	-$0.20est. -$0.24	+16.82%beat	$7.6M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $3.94
High: $4.21
Low: $3.72
Prev close: $3.91
52-wk high: $9.82
52-wk low: $3.08
Mkt cap: $67.2M
ROE: -240.4%
Beta: 1.67
P/S: 2.2x
P/B: 14.3x
Profit margin: -102.8%
Op margin: -87.2%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -102.8%
Market cap: $67M

Valuation

P/S2.21
P/B14.32

Quality

Operating margin-87.2%
ROE-240.4%
ROA-44.0%

Growth

Beta1.67

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

54balanced

20D volatility

92%annualized

52-week range

$3.72

$3.08$9.82

20D support

$3.08recent floor

20D resistance

$4.21recent ceiling

Returns

5D +20.4%20D -1.6%60D -25.5%

Price vs moving averages

SMA20 +6.9%SMA50 -9.2%SMA200 -31.4%

Volume pace

1.25xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 12, 2026

-$0.49est. -$0.49

+0.51%

$6.9MSEC filing

-51.8%from $14.3M

Jun 30, 2026Aug 6, 2026

-$0.48est. -$0.47

-2.86%

$5.9MSEC filing

-53.8%from $12.7M

Mar 31, 2026May 12, 2026

-$0.45est. -$0.59

+22.98%

$5.0MSEC filing

+46.1%from $3.4M

Dec 31, 2025Mar 11, 2026

-$0.51est. -$0.64

+20.31%

$5.1MYahoo Finance

No year-ago quarter

Sep 30, 2025Nov 14, 2025

-$0.03est. -$0.06

+$0.03

$14.3MSEC filing

No year-ago quarter

Jun 30, 2025Aug 12, 2025

$0.25est. -$0.83

+130.12%

$12.7MSEC filing

+145.4%from $5.2M

Mar 31, 2025May 13, 2025

-$1.00est. -$1.36

+26.47%

$3.4MSEC filing

-10.1%from $3.8M

Dec 31, 2024Mar 11, 2025

-$0.20est. -$0.24

+16.82%

$7.6M · FYSEC filing

No year-ago quarter

Verrica Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about VRCA filings

Smart money on VRCA

Questions about VRCA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Verrica Pharmaceuticals Inc

Smart money at a glance

What do analysts expect?

Questions about VRCA filings

Smart money on VRCA

Questions about VRCA filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings landed in line with what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Verrica Pharmaceuticals Inc

Overview

Questions about VRCA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Verrica Pharmaceuticals Inc

Overview

Questions about VRCA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.